Background: Previous studies have shown an association between acute myocardial
infarction and preceding respiratory infection. Contradictory evidence exists on the influence …

Background: Four observational studies and one clinical trial have suggested that influenza
vaccination is associated with a> 50% reduction in risk of cardiac sudden death, myocardial …

Acute myocardial infarction (AMI) peaks in winter months, partly linked to epidemic
influenza. This implies that influenza vaccination may prevent some cases of AMI. This study …

Introduction: Influenza vaccination may be beneficial in coronary disease patients; however
the infection and vaccination are associated with acute inflammation, a trigger of …

Background: Several studies suggest that influenza vaccination may be associated with a
decreased risk of acute cardiovascular events. We examined the association between …

Influenza and pneumococcal infections have been suggested to be potential risk factors for
causing adverse cardiovascular events, especially in high-risk patients. Vaccination against …

Studies have documented an association between influenza vaccination and risk reduction
in myocardial infarction, all-cause mortality, and major adverse cardiac events. This meta …

Objective Acute myocardial infarction (AMI) is the leading cause of death and disability
globally. There is increasing evidence from observational studies that influenza infection is …

Background Registry studies and case-control studies have demonstrated that the risk of
acute myocardial infarction (AMI) is increased following influenza infection. Small …

Background: Based on promising results from laboratory studies, we hypothesized that
pneumococcal vaccination would protect patients from myocardial infarction. Methods: We …